Loxam Teri
Insider CIK 1829111 · SQZ Chief Financial Officer · PCVX Director · CMPS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCVX Vaxcyte, Inc. | A Award deriv | 2026-06-15 | 2026-06-16 | 11,389 | — | $0 | 11,389 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2026-06-15 | 2026-06-16 | 2,265 | — | $0 | 12,481 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2026-03-26 | 2026-03-27 | 157,635 | — | $0 | 157,635 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award | 2026-03-26 | 2026-03-27 | 75,000 | — | $0 | 152,002 | SEC↗ |
| CMPS COMPASS Pathways plc | F Tax w/h | 2026-03-11 | 2026-03-13 | 1,781 | $6.89 | $12.3K | 77,002 | SEC↗ |
| CMPS COMPASS Pathways plc | F Tax w/h | 2026-03-02 | 2026-03-03 | 4,467 | $7.02 | $31.4K | 78,783 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2025-06-12 | 2025-06-16 | 15,372 | — | $0 | 15,372 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2025-06-12 | 2025-06-16 | 3,041 | — | $0 | 10,216 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2025-03-11 | 2025-03-13 | 76,000 | — | $0 | 76,000 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award | 2025-03-11 | 2025-03-13 | 25,000 | — | $0 | 83,250 | SEC↗ |
| CMPS COMPASS Pathways plc | F Tax w/h | 2025-03-03 | 2025-03-04 | 4,468 | $3.67 | $16.4K | 58,250 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-01-15 | 2025-01-17 | 6,250 | — | $0 | 6,250 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-15 | 2025-01-17 | 1,202 | $83.93 | $100.9K | 10,726 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-15 | 2025-01-17 | 1,136 | $82.89 | $94.2K | 11,928 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-15 | 2025-01-17 | 215 | $81.53 | $17.5K | 13,064 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-15 | 2025-01-17 | 146 | $80.46 | $11.7K | 13,279 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-15 | 2025-01-17 | 529 | $88.54 | $46.8K | 7,175 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-15 | 2025-01-17 | 1,013 | $87.38 | $88.5K | 7,704 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-01-15 | 2025-01-17 | 6,250 | $22.70 | $141.9K | 13,425 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-15 | 2025-01-17 | 966 | $86.26 | $83.3K | 8,717 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-15 | 2025-01-17 | 1,043 | $85.29 | $89.0K | 9,683 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-09-17 | 2024-09-18 | 6,250 | — | $0 | 12,500 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-17 | 2024-09-18 | 4,308 | $116.62 | $502.4K | 7,431 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-17 | 2024-09-18 | 1,445 | $115.32 | $166.6K | 11,739 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-17 | 2024-09-18 | 256 | $117.51 | $30.1K | 7,175 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-09-17 | 2024-09-18 | 6,250 | $22.70 | $141.9K | 13,425 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-17 | 2024-09-18 | 241 | $114.64 | $27.6K | 13,184 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 7,250 | — | $0 | 7,250 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2024-06-06 | 2024-06-10 | 1,550 | — | $0 | 7,175 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2024-03-01 | 2024-03-05 | 117,643 | — | $0 | 117,643 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award | 2024-03-01 | 2024-03-05 | 62,718 | — | $0 | 62,718 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2023-06-13 | 2023-06-15 | 2,500 | — | $0 | 5,625 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2022-06-01 | 2022-06-03 | 18,750 | — | $0 | 18,750 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2022-06-01 | 2022-06-03 | 3,125 | — | $0 | 3,125 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2021-09-16 | 2021-09-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2021-02-23 | 2021-02-25 | 75,950 | — | $0 | 75,950 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2020-10-29 | 2020-10-30 | 10,530 | — | $0 | 10,530 | SEC↗ |